461 related articles for article (PubMed ID: 24323355)
21. CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway.
Wang L; Zhang F; Cui JY; Chen L; Chen YT; Liu BW
Oncol Rep; 2018 May; 39(5):2081-2090. PubMed ID: 29565447
[TBL] [Abstract][Full Text] [Related]
22. Interleukin 17A promotes cell migration, enhances anoikis resistance, and creates a microenvironment suitable for triple negative breast cancer tumor metastasis.
Tsai YF; Huang CC; Lin YS; Hsu CY; Huang CP; Liu CY; Chiu JH; Tseng LM
Cancer Immunol Immunother; 2021 Aug; 70(8):2339-2351. PubMed ID: 33512556
[TBL] [Abstract][Full Text] [Related]
23. The eicosanoids leukotriene D4 and prostaglandin E2 promote the tumorigenicity of colon cancer-initiating cells in a xenograft mouse model.
Bellamkonda K; Chandrashekar NK; Osman J; Selvanesan BC; Savari S; Sjölander A
BMC Cancer; 2016 Jul; 16():425. PubMed ID: 27388564
[TBL] [Abstract][Full Text] [Related]
24. IL-17A Promotes the Migration and Invasiveness of Colorectal Cancer Cells Through NF-κB-Mediated MMP Expression.
Ren H; Wang Z; Zhang S; Ma H; Wang Y; Jia L; Li Y
Oncol Res; 2016; 23(5):249-56. PubMed ID: 27098148
[TBL] [Abstract][Full Text] [Related]
25. Targeting multiple tyrosine kinase receptors with Dovitinib blocks invasion and the interaction between tumor cells and cancer-associated fibroblasts in breast cancer.
Zang C; Eucker J; Habbel P; Neumann C; Schulz CO; Bangemann N; Kissner L; Riess H; Liu H
Cell Cycle; 2015; 14(8):1291-9. PubMed ID: 25714853
[TBL] [Abstract][Full Text] [Related]
26. Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment.
Lagadec C; Vlashi E; Della Donna L; Meng Y; Dekmezian C; Kim K; Pajonk F
Breast Cancer Res; 2010; 12(1):R13. PubMed ID: 20158881
[TBL] [Abstract][Full Text] [Related]
27. Candidate markers that associate with chemotherapy resistance in breast cancer through the study on Taxotere-induced damage to tumor microenvironment and gene expression profiling of carcinoma-associated fibroblasts (CAFs).
Rong G; Kang H; Wang Y; Hai T; Sun H
PLoS One; 2013; 8(8):e70960. PubMed ID: 23951052
[TBL] [Abstract][Full Text] [Related]
28. Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells.
Morrison BJ; Steel JC; Morris JC
BMC Cancer; 2018 Apr; 18(1):469. PubMed ID: 29699516
[TBL] [Abstract][Full Text] [Related]
29. T-Cell Proapoptotic and Antifibrotic Activity Against Autologous Skin Fibroblasts
Vettori S; Barra G; Russo B; Borgia A; Pasquale G; Pellecchia L; Vicedomini L; De Palma R
Front Immunol; 2020; 11():220. PubMed ID: 32174912
[No Abstract] [Full Text] [Related]
30. Asporin activates coordinated invasion of scirrhous gastric cancer and cancer-associated fibroblasts.
Satoyoshi R; Kuriyama S; Aiba N; Yashiro M; Tanaka M
Oncogene; 2015 Jan; 34(5):650-60. PubMed ID: 24441039
[TBL] [Abstract][Full Text] [Related]
31. A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer.
Wang J; Xing Y; Wang Y; He Y; Wang L; Peng S; Yang L; Xie J; Li X; Qiu W; Yi Z; Liu M
J Exp Clin Cancer Res; 2019 Oct; 38(1):422. PubMed ID: 31640758
[TBL] [Abstract][Full Text] [Related]
32. IL-17A in the tumor microenvironment of the human colorectal adenoma-carcinoma sequence.
Cui G; Yuan A; Goll R; Florholmen J
Scand J Gastroenterol; 2012 Nov; 47(11):1304-12. PubMed ID: 22989213
[TBL] [Abstract][Full Text] [Related]
33. CXCR4/TGF-β1 mediated self-differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and promoted colorectal carcinoma development.
Tan HX; Xiao ZG; Huang T; Fang ZX; Liu Y; Huang ZC
Cancer Biol Ther; 2020; 21(3):248-257. PubMed ID: 31818187
[No Abstract] [Full Text] [Related]
34. Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy.
Maccalli C; Parmiani G; Ferrone S
Immunol Invest; 2017 Apr; 46(3):221-238. PubMed ID: 28287848
[TBL] [Abstract][Full Text] [Related]
35. A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen.
Lereclus E; Tout M; Girault A; Baroukh N; Caulet M; Borg C; Bouché O; Ternant D; Paintaud G; Lecomte T; Raoul W
BMC Cancer; 2017 Mar; 17(1):220. PubMed ID: 28347290
[TBL] [Abstract][Full Text] [Related]
36. CD44 expressed on cancer-associated fibroblasts is a functional molecule supporting the stemness and drug resistance of malignant cancer cells in the tumor microenvironment.
Kinugasa Y; Matsui T; Takakura N
Stem Cells; 2014 Jan; 32(1):145-56. PubMed ID: 24395741
[TBL] [Abstract][Full Text] [Related]
37. IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling.
Shintani Y; Fujiwara A; Kimura T; Kawamura T; Funaki S; Minami M; Okumura M
J Thorac Oncol; 2016 Sep; 11(9):1482-92. PubMed ID: 27287412
[TBL] [Abstract][Full Text] [Related]
38. Sphere culture of murine lung cancer cell lines are enriched with cancer initiating cells.
Morrison BJ; Steel JC; Morris JC
PLoS One; 2012; 7(11):e49752. PubMed ID: 23152931
[TBL] [Abstract][Full Text] [Related]
39. Biological characteristics and genetic heterogeneity between carcinoma-associated fibroblasts and their paired normal fibroblasts in human breast cancer.
Peng Q; Zhao L; Hou Y; Sun Y; Wang L; Luo H; Peng H; Liu M
PLoS One; 2013; 8(4):e60321. PubMed ID: 23577100
[TBL] [Abstract][Full Text] [Related]
40. IL-17A secreted from lymphatic endothelial cells promotes tumorigenesis by upregulation of PD-L1 in hepatoma stem cells.
Wei Y; Shi D; Liang Z; Liu Y; Li Y; Xing Y; Liu W; Ai Z; Zhuang J; Chen X; Gao Q; Jiang J
J Hepatol; 2019 Dec; 71(6):1206-1215. PubMed ID: 31499129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
